Tech Company Financing Transactions
StemBioSys Funding Round
Private investors invested in a $2.7 million funding round for StemBioSys. The round closed on 12/7/2016.
Transaction Overview
Company Name
Announced On
12/7/2016
Transaction Type
Debt
Amount
$2,662,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 17 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3463 Magic Dr. 110
San Antonio, TX 78229
USA
San Antonio, TX 78229
USA
Phone
Website
Email Address
Overview
BM-HPME offers a number of advantageous benefits. Multiple studies have shown that BM-HPME enhances isolation and provides a higher quantity of usable stem cells, with a higher quality and motility, when compared to cells grown on tissue culture-treated plastic.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Catherine Burzik
Chief Executive Officer
Robert Hutchens
Browse more venture capital transactions:
Prev: 12/7/2016: Message Systems venture capital transaction
Next: 12/7/2016: CSA Medical venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs